Access Clinical Trials Inc.

​

 

 

 

If your child exhibits such symptoms as inattentiveness, hyperactivity, or impulsiveness, our study is testing previously FDA approved Focalin in a new single pill delivery system, with twenty-four hour coverage.

​

​

​

 

Your child may qualify for the Cingulate ADHD Study if he or she:

• Is 6 to 17 years old

• Has ADHD symptoms such as increased levels of inattentiveness, hyperactivity, or impulsiveness

• Has no other major illness

​

​

​

Study participation will last approximately 9 weeks and include up to 8 visits to the study center. If you are interested in learning  more, the study staff will be glad to discuss details with you.

To learn more or to see if you may qualify for the ADHD Study contact: